What is the least expensive urinary antispasmodic for urinary stress incontinence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pelvic Floor Muscle Training, Not Medications, Is First-Line Treatment for Urinary Stress Incontinence

Antispasmodic medications are not recommended for stress urinary incontinence as they have not been shown to be effective for this condition. 1, 2 Instead, pelvic floor muscle training (PFMT) is the recommended first-line treatment.

Understanding Stress Urinary Incontinence Treatment

Stress urinary incontinence (SUI) is characterized by involuntary leakage of urine during physical activities that increase intra-abdominal pressure, such as coughing, sneezing, or exercising. The American College of Physicians strongly recommends against using systemic pharmacologic therapy for stress UI due to lack of efficacy 1.

Treatment Algorithm:

  1. First-line: Pelvic Floor Muscle Training (PFMT)

    • Strong recommendation based on high-quality evidence 1, 2
    • Increases continence rates and improves quality of life
    • Low risk for adverse effects
  2. For obese women: Weight loss and exercise

    • Strong recommendation based on moderate-quality evidence 1, 2
  3. For mixed UI (stress + urge components): PFMT with bladder training

    • Strong recommendation based on moderate-quality evidence 1
  4. For persistent symptoms: Consider vaginal estrogen formulations

    • Can improve continence and stress UI symptoms 1
    • Note: Transdermal estrogen patches may worsen UI

Why Antispasmodics Are Not Indicated for Stress UI

Urinary antispasmodics (antimuscarinic agents) work by blocking acetylcholine receptors, reducing involuntary bladder contractions. These medications are effective for urge incontinence but not for stress incontinence 1, 2.

The pathophysiology of stress incontinence involves weakness of the urethral sphincter and pelvic floor muscles rather than detrusor muscle overactivity, which explains why antimuscarinic medications are ineffective for this condition 3.

Common Misconceptions

Many physicians incorrectly prescribe anticholinergic receptor antagonists for SUI "despite the fact that these medications have never been shown to be effective in this condition" 3. This represents a significant gap in clinical practice that should be addressed.

If Medication Is Absolutely Necessary

If a patient has mixed urinary incontinence with a significant urge component that has failed bladder training, and medication is being considered for the urge component only:

  • Tolterodine may have the best balance of efficacy and side effects, with discontinuation rates due to adverse effects similar to placebo 1, 4
  • Darifenacin also has discontinuation rates due to adverse effects similar to placebo 1
  • Oxybutynin is typically less expensive but has the highest risk for discontinuation due to adverse effects (dry mouth 71.4%, constipation 15.1%, blurred vision 9.6%) 1, 5

Important Caveats

  • Adherence to pharmacological treatments for UI is generally poor 2
  • At least half of women with UI do not report the issue to their physicians 2
  • Antimuscarinic medications should be used with caution in patients with:
    • Bladder outflow obstruction (risk of urinary retention)
    • Gastrointestinal obstructive disorders
    • Narrow-angle glaucoma
    • Decreased gastrointestinal motility 4

Remember that for true stress urinary incontinence, pelvic floor muscle training remains the gold standard treatment, and pharmacologic therapy is not recommended.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Urinary Incontinence Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.